PT2024748E - Anticorpos monoclonais anti-anexina a3 para a deteção de carcinoma da próstata - Google Patents

Anticorpos monoclonais anti-anexina a3 para a deteção de carcinoma da próstata

Info

Publication number
PT2024748E
PT2024748E PT77259497T PT07725949T PT2024748E PT 2024748 E PT2024748 E PT 2024748E PT 77259497 T PT77259497 T PT 77259497T PT 07725949 T PT07725949 T PT 07725949T PT 2024748 E PT2024748 E PT 2024748E
Authority
PT
Portugal
Prior art keywords
annexin
antibodies
detection
monoclonal anti
prostate carcinoma
Prior art date
Application number
PT77259497T
Other languages
English (en)
Inventor
Andre Schrattenholz
Original Assignee
Proteosys Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteosys Ag filed Critical Proteosys Ag
Publication of PT2024748E publication Critical patent/PT2024748E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4718—Lipocortins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT77259497T 2006-06-09 2007-06-11 Anticorpos monoclonais anti-anexina a3 para a deteção de carcinoma da próstata PT2024748E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81208906P 2006-06-09 2006-06-09
US85948906P 2006-11-17 2006-11-17

Publications (1)

Publication Number Publication Date
PT2024748E true PT2024748E (pt) 2013-01-16

Family

ID=38653814

Family Applications (1)

Application Number Title Priority Date Filing Date
PT77259497T PT2024748E (pt) 2006-06-09 2007-06-11 Anticorpos monoclonais anti-anexina a3 para a deteção de carcinoma da próstata

Country Status (13)

Country Link
US (1) US8012697B2 (pt)
EP (1) EP2024748B1 (pt)
JP (1) JP2009540278A (pt)
KR (1) KR20090023372A (pt)
AU (1) AU2007256377B2 (pt)
CA (1) CA2654330A1 (pt)
DE (1) DE07725949T1 (pt)
DK (1) DK2024748T3 (pt)
ES (1) ES2396730T3 (pt)
PL (1) PL2024748T3 (pt)
PT (1) PT2024748E (pt)
RU (1) RU2467335C2 (pt)
WO (1) WO2007141043A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1724586A3 (en) * 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment
EP2344544A2 (en) * 2008-09-26 2011-07-20 ProteoSys AG Novel antibodies recognizing native annexin a3
FR2968767B1 (fr) * 2010-12-08 2012-12-21 Biomerieux Sa Procede et coffret pour le diagnostic in vitro du cancer de la prostate
WO2013076222A1 (en) 2011-11-23 2013-05-30 Proteosys Ag Differential annexin a3 measurements of serum and blood derivatives or fractions thereof for the diagnosis of prostate cancer
FR2991777B1 (fr) 2012-06-07 2015-08-21 Biomerieux Sa Procede de detection et/ou de dosage de l'annexine a3 d'un mammifere dans le sang ou au moins un de ses derives
US9487831B2 (en) * 2013-09-12 2016-11-08 Versitech Limited Use of annexin A3 as a diagnostic and prognostic biomarker and therapeutic target for treating hepatocellular carcinoma
US9470677B2 (en) 2013-11-28 2016-10-18 Samsung Electronics Co., Ltd. Cell with surface coated with ANXA1 and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4104910C3 (de) 1991-02-18 2000-02-24 Schloemann Siemag Ag Stahlnachbehandlungsanlage
US5136855A (en) 1991-03-05 1992-08-11 Ontario Hydro Heat pump having an accumulator with refrigerant level sensor
US20030108963A1 (en) 2001-07-25 2003-06-12 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer
DE10217254A1 (de) 2002-04-15 2003-10-23 Proteosys Ag Verwendung von Substanzen zur Behandlung von Tumoren
JP5068543B2 (ja) * 2004-02-16 2012-11-07 プロテオジス アクチェンゲゼルシャフト がんに関する診断マーカー
EP1724586A3 (en) 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment
EP1724585A1 (en) * 2005-05-21 2006-11-22 ProteoSys AG Annexin for cancer risk assessment

Also Published As

Publication number Publication date
RU2467335C2 (ru) 2012-11-20
EP2024748B1 (en) 2012-12-12
AU2007256377A1 (en) 2007-12-13
RU2008152009A (ru) 2010-07-20
CA2654330A1 (en) 2007-12-13
WO2007141043A2 (en) 2007-12-13
EP2024748A2 (en) 2009-02-18
DE07725949T1 (de) 2009-07-02
US20100233160A1 (en) 2010-09-16
WO2007141043A3 (en) 2008-03-20
PL2024748T3 (pl) 2013-05-31
AU2007256377B2 (en) 2012-11-01
DK2024748T3 (da) 2013-03-18
US8012697B2 (en) 2011-09-06
ES2396730T3 (es) 2013-02-25
KR20090023372A (ko) 2009-03-04
JP2009540278A (ja) 2009-11-19

Similar Documents

Publication Publication Date Title
HRP20181565T1 (hr) Monoklonska protutijela protiv klaudina-18 za liječenje karcinoma
PL2178921T3 (pl) Monoklonalne przeciwciała przeciwko glipikanowi-3
IL196470A (en) Antagonist antibody for cancer treatment
ZA201000049B (en) Monoclonal antibeta amyloid antibody
SG10201404801YA (en) Monoclonal antibody
IL200168A0 (en) Monoclonal anti-cxcl13 antibodies
IL193871A0 (en) Humanized anti-cd20 monoclonal antibody
EP2198055A4 (en) HUMANIZED PAI-1 ANTIBODIES
PT2024748E (pt) Anticorpos monoclonais anti-anexina a3 para a deteção de carcinoma da próstata
EP2184605A4 (en) DUAL RECOGNITION IMMUNOASSAY FOR DETECTION OF ANTIBODIES
SI2024748T1 (sl) Monoklonska anti-aneksin A3 protitelesa za detekcijo karcinoma prostate